
News|Articles|October 23, 2012
Investigational drugs to be studied for preventing Alzheimer's
Three investigational drugs will be studied in a worldwide clinical trial to determine whether they can prevent Alzheimer’s disease. In people with inherited mutations that cause early-onset Alzheimer’s, the study will seek to identify whether the drugs can improve Alzheimer’s disease biomarkers and prevent the loss of cognitive function.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
The trend toward post-infusion outpatient care of patients treated with CAR-T | ASH 2025
2
Looking ahead: What the MHE 2025 State of the Industry survey tells us about 2026
3
Music and painting dual art therapy improves cognitive and social functions of hospitalized schizophrenia patients, study suggests
4
Low uptake of shingles vaccine despite strong value proposition for older adults
5






















































